Emmanuel Rio

Emmanuel Rio

Institut De Cancérologie de l'Ouest - Saint-Herblain / France
Others
AD Scientific Index ID: 5083432
Western Cancer Institute
person_outline Emmanuel Rio's MOST POPULAR ARTICLES
1-) Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised … T Conroy, JF Bosset, PL Etienne, E Rio, É François, N Mesgouez-Nebout, ... The Lancet Oncology 22 (5), 702-715, 2021 4922021
2-) Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions JJ Bonerandi, C Beauvillain, L Caquant, JF Chassagne, V Chaussade, ... Journal of the European Academy of Dermatology and Venereology 25, 1-51, 2011 1852011
3-) Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: final results of PRODIGE 23 phase III trial, a … T Conroy, N Lamfichekh, PL Etienne, E Rio, E Francois, ... Journal of Clinical Oncology 38 (15_suppl), 4007-4007, 2020 1652020
4-) Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trialE Deutsch, C Lemanski, JP Pignon, A Levy, A Delarochefordiere, ...Annals of oncology 24 (11), 2834-2838, 2013952013
5-) Unicancer Gastrointestinal Group and Partenariat de Recherche en Oncologie Digestive (PRODIGE) Group. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative …T Conroy, JF Bosset, PL Etienne, E Rio, É François, N Mesgouez-Nebout, ...Lancet Oncol 22 (5), 702-715, 2021882021